Showing results (161-170 of 319) with videos related to
Sort By:
Pageof 32
Neurology|June 1, 1991
New pathologic observations in juvenile onset parkinsonism with dystoniaW R Gibb, H Narabayashi, M Yokochi, et al.Journal of Neurology, Neurosurgery, and Psychiatry|February 1, 1989
The substantia nigra and ventral tegmental area in Alzheimer's disease and Down's syndromeW R Gibb, C Q Mountjoy, D M Mann, et al.Brain : a Journal of Neurology|June 1, 1987
Bradyphrenia in Parkinson's disease and psychomotor retardation in depressive illness. An experimental studyD Rogers, A J Lees, E Smith, et al.Journal of Neurology, Neurosurgery, and Psychiatry|February 1, 1990
Subcutaneous apomorphine in the treatment of Parkinson's diseaseJ P Frankel, A J Lees, P A Kempster, et al.Journal of Neural Transmission|January 1, 1982
The contribution of amphetamine metabolites of (-)-deprenyl to its antiparkinsonian propertiesJ D Elsworth, M Sandler, A J Lees, et al.Journal of Neurology|January 1, 1992
Treatment of cervical dystonia hand spasms and laryngeal dystonia with botulinum toxinA J Lees, N Turjanski, J Rivest, et al.Movement Disorders : Official Journal of the Movement Disorder Society|January 1, 1989
Off-period belching due to a reversible disturbance of oesophageal motility in Parkinson's disease and its treatment with apomorphineP A Kempster, A J Lees, P Crichton, et al.Journal of Neurology, Neurosurgery, and Psychiatry|November 1, 1992
The dopaminergic response in multiple system atrophyA J Hughes, C Colosimo, B Kleedorfer, et al.Journal of Neurology, Neurosurgery, and Psychiatry|March 23, 2000
Hedonistic homeostatic dysregulation in patients with Parkinson's disease on dopamine replacement therapiesG Giovannoni, J D O'Sullivan, K Turner, et al.Neurology|November 23, 2005
Factors influencing susceptibility to compulsive dopaminergic drug use in Parkinson diseaseA H Evans, A D Lawrence, J Potts, et al.Pageof 32